News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication May 10, 2020 Modeling Endoscopic Improvements Brian Feagan, Christopher Ma, Geert D’Haens, Vipul Jairath Read Now
Publication May 10, 2020 Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis Brian Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Vipul Jairath Read Now
Publication May 10, 2020 Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016) Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 10, 2020 Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions Niels Vande Casteele Read Now
Publication May 10, 2020 Adalimumab for Maintenance of Remission in Crohn’s Disease Brian Feagan, Vipul Jairath Read Now
Publication Mar 19, 2020 JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease Niels Vande Casteele Read Now
